Introduction
Nicotine, in its unadulterated form is odourless and only takes the distinctive whiff of tobacco after exposure to air. It is considered to be the most widely used stimulant next to caffeine. 1 It is prone to varying grades of abuse. It may be used nonchalantly or with the same uncontrollability as other communally unaccepted drug, particularly via smoking. 1 Nicotine is also readily available in various forms of nicotine replacement therapy such as transdermal patches and nicotine chewing gums. Nicotine is the main component of tobacco smoke. After inhalation, it is distributed through the blood stream and can cross the blood-brain barrier. It takes only a few seconds to reach the brain. 2, 3 Nicotine acts on the neuronal nicotinic acetylcholine receptors (nAChR), located on cholinergic synapses in the peripheral and central nervous system. 4 Nicotine has been considered to have many adverse effects, but in the last decade it has been the subject of potential therapeutic value for the management of neurologic and neurodegenerative diseases. 5, 6 Hence, research on the effects of nicotine in the body, especially on the central nervous system are continuous. The present study examined the effects of its chronic subcutaneous administration on hippocampal and striatal microstructure in both female and male rats.
Methods

Animal Care and Drug administration
Forty adult Wistar rats (150-200 g) were used for this study. There were 20 females and 20 males rats. The rats were ranAbstrAct background: Nicotine is a subject of continuous research because of its likely ameliorative effects on neurologic and neurodegenerative disorders. Purpose: This study examined the effects of its chronic subcutaneous administration on hippocampal and striatal microstructure in both female and male rats. Methods: Forty adult female and male Wistar rats were divided into 4 groups. Three experimental groups were administered nicotine via subcutaneous injections at doses of 0.25, 2 and 4 mg/kg body weight for 28 days. Control groups received normal saline. Following administration, routine processing of brain tissues was carried out. Sections obtained were stained using routine H&E methods for general histological appearance, Cresyl violet methods for nissl substances, and Bielschwolsky silver impregnation method for neuritic plaques and neurofibrillary tangles. results: The study showed significant increase in percentage of neurons showing degenerating features in the hippocampus and striatum of both female and male rats following the higher doses of nicotine treatment. Only female rats showed positive agyrophilic (black-coloured) aggregations in the hippocampal and striatal regions after nicotine treatment. conclusion: The present study indicates that higher dose of chronic nicotine administration may induce hippocampal and striatal neurodegenerative changes. However, further studies using more specific method for studying neurodegeneration within brain regions is recommended. 
Statistical analysis
Data were analysed using One-way ANOVA, followed by Student Newman-Keuls (SNK) test for multiple comparisons, and expressed as mean ± SEM. GraphPad Prism 5 (San Diego, USA) was the software used for data analysis. P<0.05 was taken as significant difference.
results
Features of degenerating neurons, as can be seen in light microscopy study of H&E stained sections, were increasingly observed in hippocampus and striatum following the higher doses of nicotine administration to both female and male groups. These features include prominent eosinophilic cytoplasm with or without shrunken nuclei, pyknotic nuclei, and neuronal swelling and/or vacuolation within the cytoplasm. 14, 15 Image J analysis, revealed that in the hippocampus, there was significant increase (p<0.01) in percentage of neurons showing degenerating features only with 4 mg/kg nicotine treatment in female rats. However, in male rats, both 2 and 4 mg/kg treatment significantly increased (p<0.001) percentage of neurons showing degenerating features compared to control and 0.25 mg/kg treatment. Though, 4 mg/kg treatment resulted in significantly higher percentage compared to 2 mg/kg treatment (Fig. 1) . On the other hand, analysis of sections of the striatum revealed that 2 and 4 mg/kg treatment significantly increased (p<0.001) percentage of neurons showing degenerating features compared to control and 0.25 mg/kg treatment for both female and male rats. Though, only in male rats did 4 mg/kg treatment result in significantly higher percentage compared to 2 mg/kg treatment (Fig. 2 ).
Sections stained with Cresyl violet revealed no observable differences in intensity of hippocampal and striatal nissl substances following nicotine administrations in female rats. However, male rats showed better intensity of hippocampal nissl substances following 0.25 mg/kg but no observable difference in the striatum (Figs. 3 and 4, Table 1 ).
Bielschwolsky silver impregnation method showed positive agyrophilic (black-coloured) aggregations in the hippocampal and striatal regions of nicotine treated female rats. These are suggestive of neuritic plaques and neurofibrillary tangles formation. However, such agyrophilic (black-coloured) aggregations were absent in both the hippocampus and striatum of male rats (Figs. 5 and 6 ).
discussion
The result of the present study indicates that chronic nicotine administration increased number of neurons showing degenerating features in the hippocampus and striatum at higher doses of 2 and 4 mg/kg treatment. Results suggest that 4 mg/kg treatment consistently increased degenerating 
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Higher doses of nicotine have previously been shown to produce selective degeneration in the brain. A study has shown that nicotine could damage the adult cerebellum by depleting the white core of the cerebellum, at high doses of 5 and 10 mg/kg administered for 60 days. 16 However, Carlson et al., observed that high doses of 15, 13, 7 and 3 mg/kg administered for 5 days produced degeneration that was specific to axons of the fasciculus retroflexus (FR); a major pathway for dopaminergic targets and other limbic structures onto important midbrain targets such as substantia nigra and ventral tegmental area. 17 The axons of FR represent a weak link subject to
A AN NN NA AL LS S RES ARTICLE degeneration by major drugs of abuse including cocaine and amphetamines. 17, 18 However, low dose of 1.7 mg/kg nicotine treatment for 5 days produced no such degenerative changes. 17 In view of these, the increase in degenerating features in the hippocampus and striatum as shown in the present study may represent significant neurodegeneration in these brain regions.
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Nissl substances staining in the brain regions studied, showed no observable differences in both female and male rats compared to their corresponding controls, except in hippocampus of male rats following 0.25 mg/kg treatment. Increase in nissl substance staining at low dose in the male hippocampus may be suggestive of enhanced synthesis of intercellular proteins, as nissl substances represent rough endoplasmic reticulum within cells. [19] [20] It is also important to note that only female rats showed features suggestive of neuritic plaques and neurofibrillary tangles formation. This alludes to the fact that the female brains may be more prone to negative effects of nicotine administration when such exposure takes place. In fact, reports have previously suggested that when nicotine does produce negative effects on brain and behaviours, females show more debilitating changes than males. 21 Although certain studies indicate that brain injury caused by other chemicals like scopalmine, diazapem, and omega N-nitro-L-arginine (LNNA) have more deteriorating effect on male mice, [22] [23] [24] the present study possibly indicate nicotine to be specifically hampering female brain activity.
In conclusion, the present study indicates that higher doses of chronic nicotine administration may induce neurodegenerative changes in the hippocampal and striatal brain regions. Some behavioural data (not included here) from this study did not show detrimental effects of nicotine on behaviours associated with the hippocampus and striatum. Thus we suggest that degenerating features seen may not be damaging enough to produce consequential changes in behaviour. In view of these we recommend further studies using more specific method for studying neurodegeneration within brain regions such as the fluoro-Jade-C staining.
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